Publication, Part of National Diabetes Audit

Report 1: Care Processes and Treatment Targets 2019 - 20, Full Report

Audit, Survey, Other reports and statistics

Publication Date:: 12 Aug 2021
Geographic Coverage:: England, Wales
Geographical Granularity:: NHS Trusts, GP practices, Integrated Care Boards, Regions
Date Range:: 01 Jan 2019 to 31 Mar 2020

Summary

The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) which is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England. The NDA is managed by NHS Digital in partnership with Diabetes UK. The National Diabetes Audit (NDA) provides a comprehensive view of diabetes care in England and Wales. It measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards. The NDA supports improvement in the quality of diabetes care by enabling participating NHS services and organisations to: Assess local practice against NICE guidelines. Compare their care, and care outcomes, with similar services and organisations. Identify gaps or shortfalls that are priorities for improvement. Identify and share best practice and provide a comprehensive national picture of diabetes care and outcomes in England and Wales.

This is the annual national report of care process completion and treatment target attainment. A 2019-20 data release was published in December 2020.

Please note, if viewing this webpage via Microsoft Edge, Excel files (.xlsx) exceeding 25MB will not be viewable using Excel Online and it may also not be possible to download the file. A zip file for "National Diabetes Audit 2019-20 Data Release, Interactive Report England" is available for download. Alternatively, please use another browser, such as Google Chrome, to automatically download the file.

Highlights

Primary care participation stood at 99.3 per cent in 2019-20 in England and Wales.

In all but six English Clinical Commissioning Groups (CCGs) and Welsh Local Health Boards (LHBs) (136 of 142), GP practice participation was 95 per cent and over. Participation did not fall below 88 per cent in any CCG/LHB.

98 specialist services participated in 2019-20 in England.

•38 services submitted both the NDA core dataset and the insulin pump dataset

•5 services submitted only the insulin pump dataset

•55 services submitted only the NDA core dataset

Specialist services generally take the lead in care for Type 1 diabetes services and also often for younger people with Type 2 diabetes. More comprehensive involvement in the audit by specialist services is important as part of the drive to improve the care received by their patients.